D.E. Shaw & Co’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.7M Sell
77,700
-100
-0.1% -$47.8K 0.02% 750
2025
Q4
$45.3M Buy
77,800
+23,900
+44% +$12.2M 0.02% 762
2025
Q3
$24.7M Buy
53,900
+30,800
+133% +$11.5M 0.01% 1038
2025
Q2
$6.99M Buy
23,100
+700
+3% +$209K 0.01% 1769
2025
Q1
$7.42M Sell
22,400
-47,200
-68% -$15.5M 0.01% 1615
2024
Q4
$21.5M Buy
69,600
+15,800
+29% +$4.44M 0.02% 996
2024
Q3
$11.4M Buy
53,800
+8,900
+20% +$2.28M 0.01% 1337
2024
Q2
$12.6M Sell
44,900
-7,900
-15% -$1.88M 0.01% 1189
2024
Q1
$14.1M Buy
52,800
+18,300
+53% +$4.31M 0.01% 1141
2023
Q4
$7.98M Buy
34,500
+10,000
+41% +$1.75M 0.01% 1542
2023
Q3
$3.58M Buy
24,500
+20,700
+545% +$3.9M ﹤0.01% 2117
2023
Q2
$878K Hold
3,800
﹤0.01% 3163
2023
Q1
$921K Buy
+3,800
New +$1.04M ﹤0.01% 3217
2019
Q2
Sell
-13,800
Closed -$1.73M 3774
2019
Q1
$1.73M Hold
13,800
﹤0.01% 2258
2018
Q4
$1.56M Buy
13,800
+10,000
+263% +$1.55M ﹤0.01% 2356
2018
Q3
$814K Buy
+3,800
New +$954K ﹤0.01% 2813

Other funds holding MDGL